nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—AR—penis—metabolic syndrome X	0.135	0.641	CbGeAlD
Oxandrolone—AR—Nongenotropic Androgen signaling—SHBG—metabolic syndrome X	0.0713	0.11	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—NR1H3—metabolic syndrome X	0.0559	0.086	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—SMEK2—metabolic syndrome X	0.0484	0.0744	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR1H3—metabolic syndrome X	0.0442	0.068	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—NR1I3—metabolic syndrome X	0.0409	0.0629	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—NR1I2—metabolic syndrome X	0.0374	0.0576	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR1I3—metabolic syndrome X	0.0323	0.0497	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR1I2—metabolic syndrome X	0.0296	0.0455	CbGpPWpGaD
Oxandrolone—Drostanolone—SHBG—metabolic syndrome X	0.0223	0.161	CrCbGaD
Oxandrolone—AR—cardiovascular system—metabolic syndrome X	0.0218	0.103	CbGeAlD
Oxandrolone—AR—kidney—metabolic syndrome X	0.0213	0.101	CbGeAlD
Oxandrolone—Danazol—CCL2—metabolic syndrome X	0.0212	0.152	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—FMO3—metabolic syndrome X	0.0196	0.0301	CbGpPWpGaD
Oxandrolone—AR—adipose tissue—metabolic syndrome X	0.0192	0.0909	CbGeAlD
Oxandrolone—AR—Nuclear Receptors—NR3C1—metabolic syndrome X	0.0159	0.0245	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—APOB—metabolic syndrome X	0.0157	0.0242	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—PPARA—metabolic syndrome X	0.0149	0.0229	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—SIRT1—metabolic syndrome X	0.0137	0.0211	CbGpPWpGaD
Oxandrolone—AR—liver—metabolic syndrome X	0.0135	0.0638	CbGeAlD
Oxandrolone—Fluoxymesterone—SHBG—metabolic syndrome X	0.0126	0.0908	CrCbGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR3C1—metabolic syndrome X	0.0126	0.0193	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—PPARG—metabolic syndrome X	0.0123	0.0189	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—NR3C1—metabolic syndrome X	0.0122	0.0187	CbGpPWpGaD
Oxandrolone—Danazol—SHBG—metabolic syndrome X	0.012	0.0868	CrCbGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.0118	0.0181	CbGpPWpGaD
Oxandrolone—Spironolactone—SHBG—metabolic syndrome X	0.0115	0.0831	CrCbGaD
Oxandrolone—AR—FOXA1 transcription factor network—INS—metabolic syndrome X	0.0107	0.0165	CbGpPWpGaD
Oxandrolone—Norethindrone—SHBG—metabolic syndrome X	0.0107	0.0772	CrCbGaD
Oxandrolone—Methyltestosterone—SHBG—metabolic syndrome X	0.0102	0.0733	CrCbGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.00973	0.015	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—SIRT1—metabolic syndrome X	0.00907	0.014	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—GCK—metabolic syndrome X	0.00893	0.0137	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—metabolic syndrome X	0.00868	0.0134	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—HMGCR—metabolic syndrome X	0.008	0.0123	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.00763	0.0117	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—NR3C1—metabolic syndrome X	0.00749	0.054	CrCbGaD
Oxandrolone—Spironolactone—NR3C1—metabolic syndrome X	0.00686	0.0494	CrCbGaD
Oxandrolone—Progesterone—SHBG—metabolic syndrome X	0.00624	0.045	CrCbGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—metabolic syndrome X	0.00606	0.00932	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—SIRT1—metabolic syndrome X	0.00594	0.00914	CbGpPWpGaD
Oxandrolone—Testosterone—SHBG—metabolic syndrome X	0.0059	0.0425	CrCbGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—AKT1—metabolic syndrome X	0.00573	0.00882	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.00559	0.00859	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—NR3C1—metabolic syndrome X	0.00514	0.0079	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.00511	0.00786	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EDC4—metabolic syndrome X	0.00504	0.00775	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.00493	0.00758	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.00472	0.00726	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—IRS1—metabolic syndrome X	0.00418	0.00643	CbGpPWpGaD
Oxandrolone—Progesterone—NR3C1—metabolic syndrome X	0.00371	0.0267	CrCbGaD
Oxandrolone—AR—Gene Expression—NR1H3—metabolic syndrome X	0.00367	0.00565	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—AKT1—metabolic syndrome X	0.00333	0.00513	CbGpPWpGaD
Oxandrolone—Norethindrone—ALB—metabolic syndrome X	0.00322	0.0232	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.00321	0.00494	CbGpPWpGaD
Oxandrolone—Methyltestosterone—ALB—metabolic syndrome X	0.00306	0.022	CrCbGaD
Oxandrolone—AR—Gene Expression—NR1I3—metabolic syndrome X	0.00269	0.00414	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.00266	0.0041	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—metabolic syndrome X	0.00266	0.00409	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—AKT1—metabolic syndrome X	0.00246	0.00379	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NR1I2—metabolic syndrome X	0.00246	0.00378	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR3C1—metabolic syndrome X	0.00217	0.00334	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.00211	0.00325	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PPARA—metabolic syndrome X	0.00203	0.00313	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.00192	0.00296	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.0018	0.00276	CbGpPWpGaD
Oxandrolone—Testosterone—ALB—metabolic syndrome X	0.00177	0.0128	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.00171	0.00262	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PPARG—metabolic syndrome X	0.00168	0.00259	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AKT1—metabolic syndrome X	0.00161	0.00248	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	0.00151	0.00233	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.00134	0.00206	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SIRT1—metabolic syndrome X	0.00118	0.00181	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NR3C1—metabolic syndrome X	0.00104	0.00161	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PPARA—metabolic syndrome X	0.000979	0.00151	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PPARG—metabolic syndrome X	0.000809	0.00125	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SERPINE1—metabolic syndrome X	0.000729	0.00112	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—AKT1—metabolic syndrome X	0.00032	0.000492	CbGpPWpGaD
